9.2 Packaging: PPPA & Child-Resistant Containers

Federal Baseline: The Poison Prevention Packaging Act

The Poison Prevention Packaging Act (PPPA) (15 U.S.C. § 1471 et seq.; implementing regulations at 16 CFR Part 1700) is the controlling federal law for household drug packaging nationwide, including New York. It requires that most prescription drugs and many OTC drug products be dispensed in child-resistant (CR) packaging — packaging designed to be significantly difficult for young children to open but not unreasonably difficult for adults to use correctly.

The federal testing protocol at 16 CFR § 1700.20 sets specific numeric thresholds that MPJE questions occasionally probe directly:

Federal PPPA Exemptions

The PPPA and its regulations carve out standard exemptions:

• Prescriber or patient request. The prescriber may authorize non-CR packaging on a prescription, or the patient (or caregiver) may request it.
• Single OTC dose. A single, non-reclosable dose (e.g., one blister-packed tablet) is exempt.
• Institutional/unit-dose use. Unit-dose packaging intended for institutional settings such as hospitals and long-term care facilities is generally exempt.
• Enumerated drug-specific exemptions. The Consumer Product Safety Commission has exempted a short, specific list of products by regulation (16 CFR § 1700.14), such as certain sublingual nitroglycerin products and oral contraceptives dispensed in their original mnemonic (memory-aid) packaging.

New York's Overlay: 8 NYCRR § 29.7(a)(9)

New York layers state professional-discipline consequences directly onto the federal CR packaging duty. 8 NYCRR § 29.7(a)(9) defines "failure to package a drug in a child-resistant container unless either the prescriber or the patient requests otherwise" as unprofessional conduct — meaning a CR packaging failure is not just a federal compliance issue but grounds for New York State Board of Pharmacy discipline. Two features go beyond a bare restatement of federal law:

1. Documentation duty. The regulation requires that a prescriber's or patient's non-CR request be documented in the pharmacy's records — an undocumented verbal request is not, by itself, a defense to a misconduct charge.
2. No reuse of CR containers. New York explicitly states that child-resistant containers shall not be reused. This is a New York-specific rule; the federal PPPA regulates a container's CR performance standard but does not itself bar reuse of a container that still passes testing. A pharmacy that refills a patient's own CR vial — rather than dispensing a fresh one — violates New York's professional-conduct rule even if the reused container would still pass a CR performance test.

Practical Application: What the Documentation Must Show

Because a non-CR request must be documented, well-run New York pharmacies keep a durable record — a note in the patient profile, an annotation on the hard-copy prescription, or a signed waiver — showing who requested non-CR packaging (prescriber or patient) and when. A pharmacist who simply "remembers" a patient's stated preference without a documented record is exposed if the Board later reviews the file.

Blanket Waivers vs. Per-Prescription Requests

A non-CR request does not need to be re-obtained for every single fill. Once a patient's (or prescriber's) request is documented in the pharmacy's records — for example, as a standing note on the patient profile — it can reasonably be treated as a blanket waiver covering that patient's future prescriptions, unless and until the patient revokes it or asks for CR packaging again. This is why the documentation requirement matters more than the request itself: a pharmacy with a clean, dated record in the patient's file has a defensible basis for continuing to dispense in non-CR containers on refills, while a pharmacy relying on staff memory does not.

Customized Patient Medication Packages: A Higher Packaging Standard

For multi-drug compliance packaging under 8 NYCRR § 29.7(a)(15) (see § 9.1), the packaging standard exceeds a simple CR vial: the container must be moisture-proof and either non-reclosable or constructed to show evidence of opening or tampering. This reflects that compliance packaging is often used by elderly or cognitively impaired patients, where both child-safety and tamper-evidence matter simultaneously.

Common MPJE Traps

• Assuming a patient's verbal request for non-CR packaging is sufficient — New York requires it be documented in the pharmacy's records.
• Refilling a returned CR vial instead of dispensing a fresh one — New York bars reuse of CR containers outright, regardless of whether the container would still pass a CR performance test.
• Treating "senior-friendly" packaging as automatically non-CR-compliant — it is permitted only if it still meets CR performance standards; "easier to open" and "not child-resistant" are not synonyms.
• Believing the PPPA is enforced only at the federal level in New York — § 29.7(a)(9) makes a packaging failure a state disciplinary matter as well.